Search results

Please enter search term
Slaughter and May advised the Ministry of Defence - £82 million sale of the Government Pipeline and Storage System Slaughter and May advised the Ministry of Defence (MoD) on its sale of the Government Pipeline and Storage System (GPSS) to Compañía Logística de Hidrocarburos (CLH) for £82 million Slaughter and May advised GlaxoSmithKline - sale of part of its stake in Aspen and its entire stake in Genmab Slaughter and May advised GlaxoSmithKline plc (GSK) on the sale of approximately half of its 12.4% stake in Aspen Pharmacare Holdings Ltd (Aspen) which was announced on 13 March 2015. Slaughter and May advises Puma Energy - acquisition of Murphy Oil's UK sites Slaughter and May advised Puma Energy in connection with its proposed acquisition from Murco Petroleum Limited, a subsidiary of Murphy Oil Corporation, of the Milford Haven facility in Wales. Slaughter and May advises ITV - acquisition of Talpa for initial cash consideration of approximately £355 million Slaughter and May, working as a team with De Brauw Blackstone Westbroek, is advising ITV plc (ITV) on its acquisition of Talpa Media B.V. Slaughter and May advised China International Capital Corporation Hong Kong Securities Limited - privatisation of Hunan Nonferrous Metals Corporation Limited Slaughter and May, Hong Kong, advised in relation to the privatisation of Hunan Nonferrous Metals Corporation Limited (HNMCL). Slaughter and May advises Taylor Wimpey - updating and extension of £550 million revolving credit facility Slaughter and May advised Taylor Wimpey plc, one of the largest residential developers in the UK, on the updating and extension of its £550 million revolving credit facility. Santander Consumer (UK) as originator - SCUK's Motor-2015 UK auto loan ABS transaction Slaughter and May advised Santander Consumer (UK) plc (SCUK) as originator in relation to SCUK's Motor-2015 UK auto loan ABS transaction. Slaughter and May is advising GlaxoSmithKline - completion of major three-part inter-conditional transaction with Novartis Slaughter and May is advising GlaxoSmithKline (GSK) on its major three-part inter-conditional transaction with Novartis which completed on 2 March 2015. Slaughter and May is advising Stripe - expansion into the EU Slaughter and May is advising Stripe, Inc., the US-based online payment services provider, in connection with its expansion into the EU. Slaughter and May is advising Grupo Villar Mir - proposed combination involving its subsidiary Grupo FerroAtlántica Slaughter and May is advising Grupo Villar Mir, one of Spain's largest private companies and a leading global industrial group, on English law aspects of the proposed combination of its wholly-owned subsidiary Grupo FerroAtlántica (FerroAtlántica) with Gl...